Dominic O'Reagan | Director And Investor
New Mosaic

Dominic O'Reagan, Director And Investor, New Mosaic

Dominic O’Regan, through his company New Mosaic Ltd, works to help seed stage companies in the UK and Europe obtain investment and to commercialise towards exit or market.  This work is typically very collaborative, with close working relationships with the companies and others in his network to ensure the pitch, data room and more importantly, the thinking behind them, are ready for investment and the market.  He also makes personal angel investments in UK companies. 

Dominic has 25 years experience working with pharmaceutical, biotech, scientific instrument and other life science business.  He has held positions in marketing, business insights, product and project development, and process streamlining, has worked with over 15 pharmaceutical and biotech companies of all sizes, and has experience in over 20 secondary care therapy areas.


On-Floor Seminar: Thursday 16th May @ 16:00

Best practice in successfully commercializing an academic spin-out company

  • Guidance for both the investor and University side at this early spin-out and seed investment stage to try and help each side understand the other’s perspectives.
  • Best practices from both investor and academic perspectives
  • Suggested advice of how to bridge the different starting points
last published: 21/Mar/19 09:25 GMT

back to speakers

There are two parts to the World Advanced Therapies & Regenerative Medicine Congress: a conference and an exhibition featuring solutions for pharma and biotech.

There is a registration fee to attend the conferences. To visit the exhibition is free.


Erica Baeta 
+44 (0)207 092 1152


Jessica Robinson 
t/ +44 (0)207 092 1150


Issa Mauthoor 
+44 (0)207 092 1257